Working… Menu

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03245385
Recruitment Status : Terminated (Sponsors decision)
First Posted : August 10, 2017
Last Update Posted : September 25, 2019
Novum Pharmaceutical Research Services
Information provided by (Responsible Party):
Sun Pharmaceutical Industries Limited

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 5, 2018
Actual Study Completion Date : February 5, 2018